These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 30422654)

  • 1. SMD-Based Interaction-Energy Fingerprints Can Predict Accurately the Dissociation Rate Constants of HIV-1 Protease Inhibitors.
    Huang S; Zhang D; Mei H; Kevin M; Qu S; Pan X; Lu L
    J Chem Inf Model; 2019 Jan; 59(1):159-169. PubMed ID: 30422654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constructing Interconsistent, Reasonable, and Predictive Models for Both the Kinetic and Thermodynamic Properties of HIV-1 Protease Inhibitors.
    Qu S; Huang S; Pan X; Yang L; Mei H
    J Chem Inf Model; 2016 Oct; 56(10):2061-2068. PubMed ID: 27624663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strength of hydrogen bond network takes crucial roles in the dissociation process of inhibitors from the HIV-1 protease binding pocket.
    Li D; Ji B; Hwang KC; Huang Y
    PLoS One; 2011 Apr; 6(4):e19268. PubMed ID: 21559397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the flap dynamics of the South African HIV subtype C protease in presence of FDA-approved inhibitors: MD study.
    Maphumulo SI; Halder AK; Govender T; Maseko S; Maguire GEM; Honarparvar B; Kruger HG
    Chem Biol Drug Des; 2018 Nov; 92(5):1899-1913. PubMed ID: 30003668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein-ligand interaction fingerprints for accurate prediction of dissociation rates of p38 MAPK Type II inhibitors.
    Zhang D; Huang S; Mei H; Kevin M; Shi T; Chen L
    Integr Biol (Camb); 2019 Feb; 11(2):53-60. PubMed ID: 30855664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic molecular dynamics, MM-PBSA, and ab initio approaches to the saquinavir resistance mechanism in HIV-1 PR due to 11 double and multiple mutations.
    Tzoupis H; Leonis G; Avramopoulos A; Mavromoustakos T; Papadopoulos MG
    J Phys Chem B; 2014 Aug; 118(32):9538-52. PubMed ID: 25036111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A contribution to the drug resistance mechanism of darunavir, amprenavir, indinavir, and saquinavir complexes with HIV-1 protease due to flap mutation I50V: a systematic MM-PBSA and thermodynamic integration study.
    Leonis G; Steinbrecher T; Papadopoulos MG
    J Chem Inf Model; 2013 Aug; 53(8):2141-53. PubMed ID: 23834142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-drug resistance profile of PR20 HIV-1 protease is attributed to distorted conformational and drug binding landscape: molecular dynamics insights.
    Chetty S; Bhakat S; Martin AJ; Soliman ME
    J Biomol Struct Dyn; 2016; 34(1):135-51. PubMed ID: 25671669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interdependence of Inhibitor Recognition in HIV-1 Protease.
    Paulsen JL; Leidner F; Ragland DA; Kurt Yilmaz N; Schiffer CA
    J Chem Theory Comput; 2017 May; 13(5):2300-2309. PubMed ID: 28358514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accurate ensemble molecular dynamics binding free energy ranking of multidrug-resistant HIV-1 proteases.
    Sadiq SK; Wright DW; Kenway OA; Coveney PV
    J Chem Inf Model; 2010 May; 50(5):890-905. PubMed ID: 20384328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accurate prediction of relative binding affinities of a series of HIV-1 protease inhibitors using semi-empirical quantum mechanical charge.
    Peng C; Wang J; Xu Z; Cai T; Zhu W
    J Comput Chem; 2020 Jul; 41(19):1773-1780. PubMed ID: 32352193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the pH-dependencies of the association and dissociation kinetics of HIV-1 protease inhibitors.
    Gossas T; Danielson UH
    J Mol Recognit; 2003; 16(4):203-12. PubMed ID: 12898670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of active site mutations of South African HIV PR on drug resistance: Insight from molecular dynamics simulations, binding free energy and per-residue footprints.
    Ahmed SM; Maguire GE; Kruger HG; Govender T
    Chem Biol Drug Des; 2014 Apr; 83(4):472-81. PubMed ID: 24267738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring inhibitor-induced conformational population shifts in HIV-1 protease by pulsed EPR spectroscopy.
    Blackburn ME; Veloro AM; Fanucci GE
    Biochemistry; 2009 Sep; 48(37):8765-7. PubMed ID: 19691291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into the functional role of protonation states in the HIV-1 protease-BEA369 complex: molecular dynamics simulations and free energy calculations.
    Chen J; Yang M; Hu G; Shi S; Yi C; Zhang Q
    J Mol Model; 2009 Oct; 15(10):1245-52. PubMed ID: 19294437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revealing origin of decrease in potency of darunavir and amprenavir against HIV-2 relative to HIV-1 protease by molecular dynamics simulations.
    Chen J; Liang Z; Wang W; Yi C; Zhang S; Zhang Q
    Sci Rep; 2014 Nov; 4():6872. PubMed ID: 25362963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational studies of darunavir into HIV-1 protease and DMPC bilayer: necessary conditions for effective binding and the role of the flaps.
    Leonis G; Czyżnikowska Ż; Megariotis G; Reis H; Papadopoulos MG
    J Chem Inf Model; 2012 Jun; 52(6):1542-58. PubMed ID: 22587384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural studies on molecular mechanisms of Nelfinavir resistance caused by non-active site mutation V77I in HIV-1 protease.
    Gupta A; Jamal S; Goyal S; Jain R; Wahi D; Grover A
    BMC Bioinformatics; 2015; 16 Suppl 19(Suppl 19):S10. PubMed ID: 26695135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociation and association of the HIV-1 protease dimer subunits: equilibria and rates.
    Darke PL; Jordan SP; Hall DL; Zugay JA; Shafer JA; Kuo LC
    Biochemistry; 1994 Jan; 33(1):98-105. PubMed ID: 8286367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and dynamical properties of different protonated states of mutant HIV-1 protease complexed with the saquinavir inhibitor studied by molecular dynamics simulations.
    Aruksakunwong O; Wittayanarakul K; Sompornpisut P; Sanghiran V; Parasuk V; Hannongbua S
    J Mol Graph Model; 2006 Nov; 25(3):324-32. PubMed ID: 16504560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.